-
2024-520089-70-00
5
Cutaneous lupus erythematosus
-
2024-520414-21-00
5
Adult patients with a LVOS with large core within 9 hours of symptoms
-
2025-520632-42-00
5
axial or predominantly axial SpA with or without psoriasis
-
2025-520940-14-00
6
Pyogenic liver abscess
-
2025-521101-40-00
6
CHRONIC DECOMPENSATED HEART FAILURE
-
2025-521322-14-00
4
Patients over 55 with Acute Myeloid Leukemia (AML) and IDH1 mutation,
-
2025-522118-21-00
6
Acute Anterior Uveitis
-
2025-522546-52-00
5
patients with chronic respiratory insufficiency due to amyotrophic lat
-
2025-522790-10-00
4
Non Small Cell Lung Cancer
-
2024-515181-14-00
5
2026-05-20
Patients with preoperative biliary stent treated by
pancreaticoduodene
-
2024-519444-33-00
5
2026-03-12
HER2-expressing endometrial cancer (IHC 3+/2+)
-
2023-507525-42-00
5
2025-12-23
Endometrial cancer
-
2025-520979-13-00
5
2025-12-18
Patients with HR+ HER2- early breast cancer at intermediate risk of re
-
2025-520982-39-00
5
2025-12-09
Philadelphia Chromosome Positive or ABL-class Philadelphia Chromosome-
-
2025-521125-33-00
9
2025-09-05
Ovarian Cancer
-
2024-516233-12-00
3
2025-08-08
Advanced pancreatic adenocarcinoma
-
2024-512733-32-00
5
2025-03-31
Acute Myeloid Leukemia (AML)
-
2023-507633-21-01
5
2024-12-09
Multiple Sclerosis
-
2024-514799-42-00
4
2024-11-05
IDIOPATHIC PULMONARY FIBROSIS
-
2024-517004-11-00
5
2024-10-22
Chronic pulmonary aspergillosis
-
2023-504231-41-01
10
2024-10-02
Locally advanced or metastatic urothelial cancer
-
2022-501105-12-00
5
2024-07-15
Urothelial Carcinoma
-
2023-505486-92-00
4
2024-02-09
Small bowel adenocarcinoma
-
2023-504670-38-00
4
2023-11-17
Extensive disease Small Cell Lung Cancer